Advances in radiotherapy delivery for rectal cancer: a European perspective

References

• Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-23
   PubMed Web of Science ®Google Scholar
• Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of the FFCD 9203. J Clin Oncol 2006;24:4620-5
   PubMed Web of Science ®Google Scholar
• Aschele C, Cionini L, Lonardi S, et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the START-01 randomized phase III trial. J Clin Oncol 2011;29:2773-80
   PubMed Web of Science ®Google Scholar
• Dewdney A, Cunningham D, Tabernero J, et al. EXPERT-C: A randomized phase II European multicenter trial of neoadjuvant chemotherapy (capecitabine/oxaliplatin) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined high-risk rectal cancer. J Clin Oncol 2011;29(Suppl 4); abstr 360
   PubMed Web of Science ®Google Scholar
• Gérard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase II trial ACCORD12/0405)-Prodige 2. J Clin Oncol 2010;28:1638-44
   PubMed Web of Science ®Google Scholar
• Roh M.S, et al. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. J Clin Oncol 2011;29(Suppl 4; abstr 3503
   Google Scholar
• Tournel K, De Ridder M, Engels B, et al. Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys 2008;71:934-9
   PubMed Web of Science ®Google Scholar
• Engels B, De Ridder M, Tournel K, et al. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 2009;74:1476-80
   PubMed Web of Science ®Google Scholar
• De Ridder M, Tournel K, Van Nieuwenhove Y, et al. Phase II study of preoperative helical tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:728-34
   PubMed Web of Science ®Google Scholar
• Engels B, Tournel K, Everaert H, et al. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer. Int J Radiat Oncol Biol Phys 2012;83(1):142-8
   PubMed Web of Science ®Google Scholar
• Engels B, Platteaux N, Van den Begin R, et al. Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome. Radiother Oncol 2014;110(1):155-9
   PubMed Web of Science ®Google Scholar
• Engels B, De Ridder M. Clinical implementation of intensitymodulated and image-guided radiotherapy in colorectal cancer. Belg J Med Oncol 2012;6:70-2
   Google Scholar
• Engels B, De Paoli A, Cattari G, et al. Preoperative radiotherapy with a simultaneous integrated boost compared to chemoradiotherapy for T3-4 rectal cancer: interim analysis of a multicentric randomized trial. 56th ASTRO Annual Meeting, San Francisco 2014
   Google Scholar
• Gérard JP, Ortholan C, Benezery K, et al. Contact X-ray therapy for rectal cancer: experience in Centre Antoine-Lacassagne, Nice, 2002-2006. Int J Radiat Oncol Biol Phys 2008;72(3):665-70
   PubMed Web of Science ®Google Scholar
• Verellen D, De Ridder M, Linthout N, et al. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007;7(12):949-60
   PubMed Web of Science ®Google Scholar
• De Ridder M, Van Esch G, Engels B, et al. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway. Nitric Oxide-Biology and Chemistry 2008;19(2):164-9
   PubMed Web of Science ®Google Scholar
• De Ridder M, Verovski V, Darville MI, et al. Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse. Int J Radiat Oncol Biol Phys 2004;60(2):598-606
   PubMed Web of Science ®Google Scholar
• Jiang H, Verovski VN, Leonard W, et al. Hepatocytes determine the hypoxic microenvironment and radiosensitivity of colorectal cancer cells through production of nitric oxide that targets mitochondrial respiration. Int J Radiat Oncol Biol Phys 2013;85(3):820-7
   PubMed Web of Science ®Google Scholar
• Raber P, Ochoa A, Rodríguez PC. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunol Invest 2012;41(6-7):614-34
   PubMed Web of Science ®Google Scholar
• De Ridder M, Verovski V, Chiavaroli C, et al. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase. Int J Radiat Oncol Biol Phys 2006;66(5):1473-80
   PubMed Web of Science ®Google Scholar
• Bittner MI, Wiedenmann N, Bucher S, et al. Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. Radiother Oncol 2013;108(3):511-16
   PubMed Web of Science ®Google Scholar
• Makkat S, Luypaert R, De Mey J. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings - preliminary results. Radiology 2008;249(2):471-82
   PubMed Web of Science ®Google Scholar